CCMB lab releases guidelines for coronavirus testing on zoo animals

LaCONES-CCMB releases guidelines for Covid-19 testing on zoo animals

A Zoo staff member covers his face while spraying chemicals near a rosy Pelican enclosure to prevent the Bird Flu (H5N1 avian influenza virus) at Delhi Zoo.
Press Trust of India Hyderabad
2 min read Last Updated : Jun 21 2021 | 5:50 PM IST

: The Laboratory for the

Conservation of Endangered Species (LaCONES) of CSIR-Centre for Cellular and Molecular Biology (CCMB) here has released guidelines for COVID-19 tests on captive animals.

LaCONES is one of the four designated centres for testing animal samples for possible coronavirus infection, a press release from the CCMB said on Monday.

The guidelines provide detailed protocols that include pictorials and frequently asked questions for an easier understanding of those collecting samples for COVID testing in wildlife, Vinay K Nandicoori, Director, CSIR-CCMB, said.

LaCONES started testing animal samples for possible SARS-CoV-2 coronavirus infection in August 2020.

The scientists found the first positive samples from Asiatic lions in the Nehru Zoological Park, Hyderabad, in April 2021.

At that time, LaCONES team tried testing for coronavirus using different kinds of nasal, oropharyngeal, rectal and fecal samples from the animals.

LaCONES regularly tests wildlife samples using DNA-based molecular biology tools to solve wildlife cases.

These tests are similar to the ones being used for coronavirus testing.

We hope that our recommendations help the zoo staff in collecting and packing the samples appropriately before they send out to animal testing centres will smoothen the process for the zoos as well as testing centres. Given how difficult it is to get samples from animals, it is all the more important that we make most of the samples we get, said Karthikeyan Vasudevan, scientist-in-charge, LaCONES, CSIR- CCMB, said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jun 21 2021 | 5:50 PM IST

Next Story